Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 38 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- Gut Microbiota Reconstruction for NSCLC ImmunotherapyStatus unknownNCT05008861Phase 1
- Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLCWithdrawnNCT05007769Phase 2
- Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung CancerActive, not recruitingNCT05003037Phase 2
- JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C MutationCompletedNCT05002270Phase 1/2
- KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 AgentTerminatedNCT05001724Phase 2/3
- Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line ImmunotherapyActive, not recruitingNCT05000710Phase 2
- FRAME-001 Personalized Vaccine in NSCLCStatus unknownNCT04998474Phase 2
- Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLCCompletedNCT04997382Phase 2
- A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCActive, not recruitingNCT04995523Phase 1/2
- Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung CancerActive, not recruitingNCT04994795
- PD-L1 Expression in Lung CancerStatus unknownNCT04992715Phase 2
- Nous-PEV: a Novel Immunotherapy for Lung Cancer and MelanomaTerminatedNCT04990479Phase 1
- Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT04990063Phase 1
- Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLCStatus unknownNCT04989322Phase 2
- Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung CancerWithdrawnNCT04989283Phase 2
- Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING StudyWithdrawnNCT04987281Phase 2
- NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung CancerActive, not recruitingNCT04986670Not applicable
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLCStatus unknownNCT04984148
- A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor CancerTerminatedNCT04982926Phase 1
- A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLCStatus unknownNCT04982549Phase 2
- Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced CancerTerminatedNCT04982224Phase 1
- Pulmonary Function After Arterial Sleeve LobectomyCompletedNCT04981938
- the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung CancerStatus unknownNCT04978753Phase 2
- Study of SHR-1701 Plus BP102 in Subjects With Selected Solid TumorsStatus unknownNCT04974957Phase 2
- Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung CancerStatus unknownNCT04974879Phase 2
- A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With OligoprogressionStatus unknownNCT04970693Phase 2
- Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC TreatmentStatus unknownNCT04970043Not applicable
- Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant TherapyStatus unknownNCT04968002Phase 2/3
- Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC PatientsCompletedNCT04967079Phase 1
- Study of Nivolumab-Ipilimumab and cfDNA in Lung CancerTerminatedNCT04966676Phase 2
- Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant CancerTerminatedNCT04965818Phase 1
- First Line Osimertinib in the Real World: an Inter-regional Prospective StudyCompletedNCT04965701
- A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT04965090Phase 2
- A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)Status unknownNCT04964479Phase 3
- NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNtsCompletedNCT04960059
- A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLCCompletedNCT04959981Phase 1
- A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung CancerTerminatedNCT04958993Phase 1/2
- Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells)TerminatedNCT04957602
- Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)Active, not recruitingNCT04956640Phase 1/2
- Fruquintinib Combined With Sintilimab and Chemotherapy in the Treatment of Non-Small Cell Lung CancerStatus unknownNCT04956146Phase 2
- Combination of Almonertinib and Concurrent Chemoradiotherapy in Unresectable Stage III NSCLCStatus unknownNCT04952168Phase 2
- A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR MutationStatus unknownNCT04951648Phase 3
- Fecal Microbial Transplantation Non-Small Cell Lung Cancer and MelanomaActive, not recruitingNCT04951583Phase 2
- A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung CancerCompletedNCT04951154
- Uniportal Tubeless VATS for the Evaluation of Biopsy for Second-generation Sequencing in Patients With Advanced NSCLCStatus unknownNCT04950907Not applicable
- A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLCStatus unknownNCT04950400Not applicable
- Durvalumab as Maintenance in Patients Who Received Chemoradiotherapy for Unresectable Stage III NSCLC: Real World Data From an Expanded Access Program in BrazilCompletedNCT04948411
- Breath Combined With CT for Diagnoses of Pulmonary NodulesStatus unknownNCT04948047
- Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in BrazilCompletedNCT04947683
- Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung CancerActive, not recruitingNCT04946279Not applicable
- MR-Linac Guided Adaptive FSRT for Brain Metastases From Non-small Cell Lung CancerCompletedNCT04946019Phase 2
- Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung CancerStatus unknownNCT04945200
- SCION: SABR and Checkpoint Inhibition of NSCLCWithdrawnNCT04944173Phase 2
- Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLCStatus unknownNCT04943029Phase 2
- PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based ChemotherapyStatus unknownNCT04942301Phase 1
- Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation TherapyStatus unknownNCT04942275Phase 2/3
- Neoadjuvant Immunotherapy With Chemotherapy for Stage I-IIIB Non-Small Cell Lung Cancer PatientsStatus unknownNCT04941417Phase 2
- Shared Decision Making on Radiation Dose for Lung MalignanciesActive, not recruitingNCT04940936Not applicable
- Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung CancerActive, not recruitingNCT04940325Phase 2
- Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaActive, not recruitingNCT04940299Phase 2
- Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung CancerCompletedNCT04939324Not applicable
- Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic TumorStatus unknownNCT04932343
- A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid CancerActive, not recruitingNCT04931654Phase 1/2
- Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 NegativeActive, not recruitingNCT04929041Phase 2/3
- Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) PatientsCompletedNCT04923945Phase 3
- Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR MutationsActive, not recruitingNCT04923906Phase 3
- Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)TerminatedNCT04923802
- Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLCActive, not recruitingNCT04919811Phase 2
- All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung CancerCompletedNCT04919369Phase 1
- Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC PatientsCompletedNCT04912687Not applicable
- Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without ChemotherapyTerminatedNCT04911166Phase 1
- The Prospective Non-randomized Case-control Study From Real-world Lung Cancer PatientsCompletedNCT04909164
- A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung CancerCompletedNCT04909034Not applicable
- A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1SuspendedNCT04908111Phase 1/2
- Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLCStatus unknownNCT04905550Phase 2
- A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung CancerCompletedNCT04905316Phase 2
- Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsCompletedNCT04902872Phase 1/2
- A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLCCompletedNCT04900363Phase 1/2
- Monitoring the Efficacy of Duvalizumab Combined With Neoadjuvant Chemotherapy for Ib-IIIb NSCLC by Sequencing of Immune Receptor Repertoire: a Prospective, One Arm Clinical StudyStatus unknownNCT04897386Phase 2
- Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLCStatus unknownNCT04895930Phase 2
- Lung Cancer With Copanlisib and DurvalumabCompletedNCT04895579Phase 1
- EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT04892472Phase 2
- Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid TumorsTerminatedNCT04892017Phase 1
- A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWithdrawnNCT04889495
- Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain MetastasesWithdrawnNCT04889066Phase 2
- A Study of Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC)CompletedNCT04887519
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Active, not recruitingNCT04886804Phase 1
- Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)Active, not recruitingNCT04884282Phase 2
- A Non Interventional Pilot Study on Machine Learning for ILD Detection Based on the Patient Data From Digital Devices in Unresectable Stage III Non-Small Cell Lung Cancer Patients Receiving DurvalumabCompletedNCT04884269
- Immune and Genomic Markers in ALK+ NSCLCActive, not recruitingNCT04881916
- Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.CompletedNCT04881045Phase 1
- Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer PatientsTerminatedNCT04880382Phase 2
- Energy for LymphocytesCompletedNCT04879316
- Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung CancerTerminatedNCT04878952Not applicable
- Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer TherapiesStatus unknownNCT04878692Not applicable
- SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and ChemotherapyStatus unknownNCT04878107Phase 2
- JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and SafetyStatus unknownNCT04874844Phase 2/3
- A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor TreatmentStatus unknownNCT04872634Phase 1/2
- A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)CompletedNCT04871997